Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q3 2022 Earnings

14NovExpected
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-26
-19.5
-13
-6.5

Details

Expected EPS
-13
Actual EPS
-6.5
Surprise EPS
6.5
Surprise Percent
+50%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -6.5 per share for Q3 2022.

0 Comments

Share your thoughts